WITHDRAWAL OF FENOTEROL AND THE END OF THE NEW-ZEALAND ASTHMA MORTALITY EPIDEMIC

被引：13

作者：

BEASLEY, R ^{[1
]}

PEARCE, N ^{[1
]}

CRANE, J ^{[1
]}

BURGESS, C ^{[1
]}

机构：

[1] WELLINGTON SCH MED,DEPT MED,WELLINGTON ASTHMA RES GRP,WELLINGTON,NEW ZEALAND

来源：

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY | 1995年 / 107卷 / 1-3期

关键词：

ASTHMA MORTALITY; FENOTEROL; NEW ZEALAND;

D O I：

10.1159/000237016

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

In response to the evidence that fenoterol was a major cause for the second epidemic of asthma deaths in New Zealand, the Department of Health severely restricted its availability, thereby allowing an 'experiment in prevention' to be undertaken. These regulatory actions, which effectively removed fenoterol from the market in New Zealand, were associated with a sudden and marked reduction in asthma mortality, providing further evidence for a causative role of fenoterol in the epidemic of asthma deaths in New Zealand.

引用

页码：325 / 327

页数：3

共 15 条

[11] CASE-CONTROL STUDY OF PRESCRIBED FENOTEROL AND DEATH FROM ASTHMA IN NEW-ZEALAND, 1977-81 [J].

PEARCE, N ;

GRAINGER, J ;

ATKINSON, M ;

CRANE, J ;

BURGESS, C ;

CULLING, C ;

WINDOM, H ;

BEASLEY, R .

THORAX, 1990, 45 (03) :170-175

[12]

PEARCE N, 1994, JAMA-J AM MED ASSOC, V271, P822, DOI 10.1001/jama.271.11.822

[13] THE USE OF BETA-AGONISTS AND THE RISK OF DEATH AND NEAR DEATH FROM ASTHMA [J].

SPITZER, WO ;

SUISSA, S ;

ERNST, P ;

HORWITZ, RI ;

HABBICK, B ;

COCKCROFT, D ;

BOIVIN, JF ;

MCNUTT, M ;

BUIST, AS ;

REBUCK, AS .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (08) :501-506

[14] A COHORT ANALYSIS OF EXCESS MORTALITY IN ASTHMA AND THE USE OF INHALED BETA-AGONISTS [J].

SUISSA, S ;

ERNST, P ;

BOIVIN, JF ;

HORWITZ, RI ;

HABBICK, B ;

COCKROFT, D ;

BLAIS, L ;

MCNUTT, M ;

BUIST, AS ;

SPITZER, WO .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :604-610

[15]

WILSON JD, 1981, LANCET, V1, P1235

← 1 2 →